Baidu
map

肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

大会演讲嘉宾詹启敏院士：2016 AACR“ 癌症研究新视野”大会

2016-10-20 MedSci MedSci原创

詹启敏癌症
关注

<div><a href="https://img.medsci.cn/webeditor/uploadfile/201610/20161021093824244.png" target="_blank"><img src="https://img.medsci.cn/webeditor/uploadfile/201610/20161021093824244_s.png" border="0"></a><br></div><div><br></div><div><br></div><div><span style="font-size: 16pt; font-weight: bold;">大会演讲嘉宾</span></div><a href="https://img.medsci.cn/webeditor/uploadfile/201610/20161021093315796.jpg" target="_blank"><img src="https://img.medsci.cn/webeditor/uploadfile/201610/20161021093315796_s.jpg"




大会演讲嘉宾


中国工程院院士，北京大学医学部主任，分子肿瘤学国家重点实验室主任，教育部***特聘教授，国家杰出青年科学基金获得者，国家973肿瘤研究项目首席科学家，国家基金委创新群体首席专家。先后担任中国微循环学会理事长，中国抗癌协会副理事长，国家863高技术计划医药生物技术专家组组长，国家卫生计生委科技行业专项专家委员会主任，国家新药创制重大专项生物药责任专家组组长，《中国生化药物杂志》主编，《中华肿瘤》和《转化医学》杂志副主编，《J Biol Chem》、《Cancer Biol and Ther》、《Carcinogenesis》、《Molecular Oncology》等国际学术杂志编委。负责医学部全面工作，分管人事、科研、国际合作、审计工作。

　　长期从事肿瘤分子肿瘤学和转化医学研究，在国际上率先发现和系统揭示了细胞周期监测点关键蛋白的作用和机制，阐明多个重要细胞周期调控蛋白在细胞癌变和肿瘤诊断与个体化治疗中的作用。发表SCI论文200多篇，包括 Nature ， Cell, J Clin Invest, EMBO, Mol Cell Biol, Science, Cancer Res, Oncogene, J Biol Chem and PNAS , 发表论文的SCI引用12000多次，主编著作5部。应邀在国内外学术会议上作大会报告120余次，9次担任国际（双边）会议共同主席。

大会日程






版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1400351, encodeId=f076140035134, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439086, encodeId=48bb143908657, content=<a href='/topic/show?id=a993910865f' target=_blank style='color:#2F92EE;'>#詹启敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91086, encryptionId=a993910865f, topicName=詹启敏)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514164, encodeId=74811514164b7, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551976, encodeId=01ba15519e6a4, content=<a href='/topic/show?id=169c166430' target=_blank style='color:#2F92EE;'>#AACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1664, encryptionId=169c166430, topicName=AACR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b2714248200, createdName=Luyuxie_14, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149917, encodeId=3f8f14991eba, content=很不错的技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Oct 20 11:59:53 CST 2016, time=2016-10-20, status=1, ipAttribution=)]
    2016-10-22 10518094zz

    #ACR#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1400351, encodeId=f076140035134, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439086, encodeId=48bb143908657, content=<a href='/topic/show?id=a993910865f' target=_blank style='color:#2F92EE;'>#詹启敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91086, encryptionId=a993910865f, topicName=詹启敏)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514164, encodeId=74811514164b7, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551976, encodeId=01ba15519e6a4, content=<a href='/topic/show?id=169c166430' target=_blank style='color:#2F92EE;'>#AACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1664, encryptionId=169c166430, topicName=AACR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b2714248200, createdName=Luyuxie_14, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149917, encodeId=3f8f14991eba, content=很不错的技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Oct 20 11:59:53 CST 2016, time=2016-10-20, status=1, ipAttribution=)]
    2016-10-22 zhouqu_8

    #詹启敏#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1400351, encodeId=f076140035134, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439086, encodeId=48bb143908657, content=<a href='/topic/show?id=a993910865f' target=_blank style='color:#2F92EE;'>#詹启敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91086, encryptionId=a993910865f, topicName=詹启敏)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514164, encodeId=74811514164b7, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551976, encodeId=01ba15519e6a4, content=<a href='/topic/show?id=169c166430' target=_blank style='color:#2F92EE;'>#AACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1664, encryptionId=169c166430, topicName=AACR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b2714248200, createdName=Luyuxie_14, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149917, encodeId=3f8f14991eba, content=很不错的技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Oct 20 11:59:53 CST 2016, time=2016-10-20, status=1, ipAttribution=)]
    2016-10-22 小华子

    #癌症研究#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1400351, encodeId=f076140035134, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439086, encodeId=48bb143908657, content=<a href='/topic/show?id=a993910865f' target=_blank style='color:#2F92EE;'>#詹启敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91086, encryptionId=a993910865f, topicName=詹启敏)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514164, encodeId=74811514164b7, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551976, encodeId=01ba15519e6a4, content=<a href='/topic/show?id=169c166430' target=_blank style='color:#2F92EE;'>#AACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1664, encryptionId=169c166430, topicName=AACR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b2714248200, createdName=Luyuxie_14, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149917, encodeId=3f8f14991eba, content=很不错的技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Oct 20 11:59:53 CST 2016, time=2016-10-20, status=1, ipAttribution=)]
    2016-10-22 Luyuxie_14

    #AACR#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1400351, encodeId=f076140035134, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439086, encodeId=48bb143908657, content=<a href='/topic/show?id=a993910865f' target=_blank style='color:#2F92EE;'>#詹启敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91086, encryptionId=a993910865f, topicName=詹启敏)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514164, encodeId=74811514164b7, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551976, encodeId=01ba15519e6a4, content=<a href='/topic/show?id=169c166430' target=_blank style='color:#2F92EE;'>#AACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1664, encryptionId=169c166430, topicName=AACR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b2714248200, createdName=Luyuxie_14, createdTime=Sat Oct 22 02:34:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149917, encodeId=3f8f14991eba, content=很不错的技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Oct 20 11:59:53 CST 2016, time=2016-10-20, status=1, ipAttribution=)]
    2016-10-20 医路开来

    很不错的技术

    0

相关资讯

詹启敏院士：中国科技发展与精准医学

导语：首届亚太血管学术联盟深圳会议暨第三届深港澳血管论坛会议于2016年6月23-24日在深圳罗湖举行。北京大学医学部主任詹启敏院士就“精准医疗”给予了最新的解读。 24日上午，大会主席詹启敏院士作了“中国科技发展与精准医学”的精彩演说。梅斯医学作为媒体合作单位，发来现场报告。 詹启敏院士“健康梦”是“中国梦”的重要内容2014年12月习近平在调研农村医疗卫生事业发展时指出：“没有全民健康，就

詹启敏院士给2016届毕业生的原创歌曲《同窗之谊是没有血缘的亲情》

不说再见的青春，没有血缘的亲情。感谢党委宣传部、学工部、研工部、留学生办公室对MV制作的大力支持；部分图片来源于黄大无老师、黄政翔同学、牛迪同学

Nature：詹启敏院士发现与食管鳞癌基因组中8个重要基因突变

   日前，英国《自然》杂志在线发表由中国医学科学院肿瘤医院分子肿瘤学国家重点实验室主任詹启敏院士团队与华大基因、汕头大学医学院等合作取得的一项科学成果。       研究人员通过高通量测序、比较基因组杂交芯片分析、生物学功能和临床验证研究，全面系统揭示了食管鳞癌的遗传突变背景，发现了与食管鳞癌发生发展进程和临 床预后相关

梅斯医学**报道詹启敏院士在第一届肿瘤精准医学高峰论坛的精彩演讲

5月6日-7日，中国医师协会临床精准医疗专业委员会成立大会暨第一届肿瘤精准医学高峰论坛在中国上海举行。

本届大会邀请到了中国工程院院士、中国医学科学院副院长、北大医学部主任詹启敏对我国的精准医学事业做了题为《精准医学发展的需求和内涵》的精彩演讲。


· 2016-05-07

-->
Baidu
map
Baidu
map
Baidu
map
Baidu
map